NCT02882750View on ClinicalTrials.gov

Effect on Patient Reported Outcomes of VATS and SABR (LILAC)

CompletedOBSERVATIONAL
Enrollment

244

Participants

Timeline

Start Date

January 25, 2016

Primary Completion Date

April 9, 2018

Study Completion Date

June 6, 2019

Conditions
Lung Cancer
Interventions
OTHER

EORTC QLQ-C30 (version 3.0).

Quality of Life Questionnaire

OTHER

PS Q18

Patients Satisfaction Questionnaire

OTHER

Decision Self-Efficacy Scale

Questionnaire

All Listed Sponsors
collaborator

Yorkshire Cancer Research

OTHER

collaborator

The Leeds Teaching Hospitals NHS Trust

OTHER

lead

University of Leeds

OTHER

NCT02882750 - Effect on Patient Reported Outcomes of VATS and SABR (LILAC) | Biotech Hunter | Biotech Hunter